Farkas, Henriette
Levy, Donald
Supina, Dylan
Berger, Melvin
Prusty, Subhransu
Fridman, Moshe
Funding for this research was provided by:
CSL Behring
Article History
Received: 16 December 2019
Accepted: 18 May 2020
First Online: 27 May 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: HF is a speaker and consultant to CSL Behring, Pharming, Biocryst, Octapharma, and Shire. DL is a researcher, speaker, and consultant to CSL Behring and speaker and consultant to Takeda. MF is a consultant to CSL Behring. DS, MB, and SP are employees of CSL Behring. MB also holds company’s stock.